CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice

Shionogi to Modernize Product Quality Management in the Cloud with Veeva Vault QMS

Pharmaceutical company in Japan unifies product quality management processes across global stakeholders
Veeva Systems today announced that Shionogi & Co., Ltd., a company in Japan, decided to select Veeva Vault QMS to improve the efficiency of product quality management across its sites inside and outside Japan. With Vault QMS, Shionogi will modernize its global product quality management processes.
Shionogi required greater simplicity and flexibility in managing its product quality management processes. The fast implementation and user-friendly configuration environment of Vault QMS are expected to provide greater agility in addressing changing business and regulatory requirements. In addition, Vault QMS is expected to help Shionogi drive seamless information management for external stakeholders with an innovative, cloud-based application.
“Shionogi is committed to continuous innovation in everything they do,” said Takashi Okamura, general manager of Veeva Japan. “We’re honored that they have chosen Veeva Vault QMS to harmonize their global product quality management processes.”
Veeva Vault QMS is a modern, cloud-based application that unifies quality management processes and internal and external stakeholders for better control and visibility. This will contribute to reducing risks related to the product quality of medicines and continuously providing patients worldwide with high-quality medicines.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026